Giving and taking feedback
By Clare Gurton (clare.gurton@rxcomms.com) Somewhere inside all of us is the desire to be ‘good’ and to be liked. And, as a result, we may find we shy away from…
DetailsHOC is our outreach and engagement site which connects us with healthcare professionals, industry personnel and academics worldwide.
Our HOC platform shares blogs from experienced medical writers around the world, bringing you tips on good communication, evaluations of current health economics and outcomes research and healthcare evidence. Mixed in with great information you will find a light-hearted approach to current issues, some valuable downloads, as well as references for further reading.
By Clare Gurton (clare.gurton@rxcomms.com) Somewhere inside all of us is the desire to be ‘good’ and to be liked. And, as a result, we may find we shy away from…
DetailsBy Jonathan Coopersmith (jonathan.coopersmith@rxcomms.com) Benjamin Franklin said “An ounce of prevention is worth a pound of cure”. Perhaps the best way to reduce errors in medicine, then, is to prevent…
DetailsBy Clare Gurton (clare.gurton@rxcomms.com) There is an increasing need for all of us to develop strategies for dealing with different cultures as business becomes more international and cross communication among…
DetailsBy Ruth Whittington (ruth.whittington@rxcomms.com) Part 3 – Conducting an observational study Last month, we looked at the differences between observational studies and randomised controlled trials (RCTs). Here, we look at…
DetailsBy David Woods (david.woods@rxcomms.com) Question: “How many people work in the public sector?” Answer: “About half of them.” It’s an old one, to be sure, but it has its echo…
DetailsBy David Woods (david.woods@rxcomms.com) If you feel that emails are inundating you, and you yearn for the days of the quill pen, help is at hand. In her recent book…
DetailsBy Amy Rothman Schonfeld (amy.schonfeld@rxcomms.com) One year after its first conference, the American Society of Health Economists (ASHE) is clearly thriving. Its membership has grown to more than 800, planning…
DetailsBy David Woods (david.woods@rxcomms.com) The theme of this year’s international ISPOR meeting – held on May 20–23 in Arlington, Virginia, USA – was “new tools, new audiences for health outcomes…
DetailsBy Ruth Whittington (ruth.whittington@rxcomms.com) Part 2 – How do observational studies and randomised controlled trials differ? Last month, I described observational studies and where they fit into the hierarchy of…
DetailsBy David Woods (dwoods@rxcomms.com) “An opportunity and a challenge”. That’s what Alan Bakst found when he became Director of Health Economics and Outcomes Research at TAP pharmaceuticals in Chicago in…
Details